HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:
Guest Access | Sign In via User Name/Password

This Article Full Text Free Full Text (PDF) Free Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to My Personal Article Archive Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by DeCamp, M. M. Articles by Jaklitsch, M. T. Search for Related Content PubMed PubMed Citation Articles by DeCamp, M. M., Jr Articles by Jaklitsch, M. T.

Esophagectomy After Induction Chemoradiation^*

^* From the Department of Thoracic and Cardiovascular Surgery (Dr. DeCamp), The Cleveland Clinic Foundation, Cleveland, OH; and the Division of Thoracic Surgery (Drs. Swanson and Jaklitsch), Brigham & Women’s Hospital, Boston, MA.

Correspondence to: Malcolm M. DeCamp, MD, FCCP, The Cleveland Clinic Foundation, Department of Thoracic and Cardiovascular Surgery/F25, 9500 Euclid Ave, Cleveland, OH 44195

The definition of a standard therapy for resectable esophageal cancer remains a clinical controversy. In the past decade, a variety of strategies have been developed in an attempt to improve local control and decrease the all too common problem of distant metastases. Preoperative treatment with radiotherapy or chemotherapy has been proved to be feasible, although neither strategy has resulted in improved survival rates. More recently, concurrent, neoadjuvant chemoradiation has been utilized with encouraging pathologic responses. Equally important is the recognition that such aggressive therapy does not lead to worse surgical outcomes. The evidence for the safety, feasibility, and efficacy of induction therapy followed by esophagectomy is presented in the context of developing a rational methodology to allow for the ongoing modification of standards of care in the management of this difficult disease.

This article has been cited by other articles:

				J. S. Donington, D. L. Miller, M. S. Allen, C. Deschamps, F. C. Nichols III, and P. C. Pairolero Preoperative chemoradiation therapy does not improve early survival after esophagectomy for patients with clinical stage III adenocarcinoma of the esophagus Ann. Thorac. Surg., April 1, 2004; 77(4): 1193 - 1199. [Abstract] [Full Text] [PDF]

				T. J. Bugno Radiation Oncology Analysis Integr Cancer Ther, March 1, 2002; 1(1): 47 - 49. [PDF]